Related Experiment Video
Updated: Jun 18, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
FXYD3: A Key Regulator of Ion Homeostasis and Redox Balance in Cancer Biology
Megha Gupta1, Satyanarayan Rao1, Rajesh Kumar1
1Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, India.
Abstract:
Cancer continues to be a major health burden, with millions of new cases and deaths reported annually, and metastasis remains the leading cause of cancer-related mortality. Disruption of transmembrane proteins is a major regulator of tumor development and progression. This review highlights FXYD3, a single-transmembrane protein that regulates Na+ /K+ -ATPase activity and functions in maintaining ion balance, redox homeostasis, and proliferative signaling in both cancer stem cells and bulk tumor populations. Its expression varies across various cancers, such as breast, pancreatic, lung, colorectal, gastric, and endometrial cancer, where it is linked with tumor development, therapy resistance, and immune modulation. Its involvement in pathways such as PI3K-AKT and cGMP-PKG contributes to malignancy. It protects cells from oxidative stress, thereby promoting cell survival and inhibiting apoptosis. Accumulating evidence highlights the potential role of FXYD3 as an emerging biomarker with relevance to diagnosis, prognosis, and therapeutics. This review provides an overview of FXYD3's role in cancer biology from translational relevance to its potential as a diagnostic, prognostic, and therapeutic target.
Insights
FXYD3, a transmembrane protein, drives cancer progression and therapy resistance by regulating ion balance and signaling pathways. Targeting FXYD3 shows potential for novel cancer diagnostics and therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer metastasis is a leading cause of mortality.
- Transmembrane protein disruption significantly impacts tumor development.
- FXYD3 regulates key cellular processes including ion balance and signaling.
Purpose of the Study:
- To review the role of FXYD3 in cancer biology.
- To highlight FXYD3's potential as a biomarker and therapeutic target.
Main Methods:
- Literature review of FXYD3's function in various cancers.
- Analysis of FXYD3's involvement in signaling pathways (e.g., PI3K-AKT, cGMP-PKG).
- Examination of FXYD3's role in cellular processes like oxidative stress response and apoptosis.
Main Results:
- FXYD3 expression varies across multiple cancer types (breast, pancreatic, lung, etc.).
- FXYD3 is implicated in tumor development, therapy resistance, and immune modulation.
- FXYD3 promotes cell survival by protecting against oxidative stress and inhibiting apoptosis.
Conclusions:
- FXYD3 is a significant regulator of cancer cell malignancy and survival.
- FXYD3 holds promise as a diagnostic and prognostic biomarker.
- Targeting FXYD3 presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Positive Regulator Molecules
Positive Regulator Molecules
